Quick Answer
Celularity Inc reported Net Income Loss of -$57.89 million for the year ending 2024.
- Celularity Inc showed an increase of +70.5% in Net Income Loss from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: -$545.00 | Q4 2018: -$1.1 thousand | Q1 2019: -$121.00 | Q2 2019: $634.7 thousand | Q3 2019: $1.12 million | Q1 2020: $6.37 million | Q2 2020: -$12.11 million | Q3 2020: -$46.33 million | Q1 2021: -$81.54 million | Q2 2021: -$64.48 million | Q3 2021: $49.94 million | Q1 2022: -$62.87 million | Q2 2022: $47.83 million | Q3 2022: $4.80 million | Q1 2023: -$64.02 million | Q2 2023: -$47.95 million | Q3 2023: -$93.88 million | Q1 2024: -$22.01 million | Q2 2024: -$6.49 million | Q3 2024: -$16.10 million | Q1 2025: -$19.75 million | Q2 2025: -$24.52 million | Q3 2025: -$23.08 million.
- Over the full 6 years of available data (2019 to 2024), Celularity Inc's Net Income Loss has declined by 2,403.7%.
- Historical annual values: Fiscal year 2024: -$57.89 million | Fiscal year 2023: -$196.30 million | Fiscal year 2022: $14.19 million | Fiscal year 2021: -$100.12 million | Fiscal year 2020: -$208.23 million | Fiscal year 2019: $2.51 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: